The efficacy of noninvasive interventionist catheterism in large animals as an alternative to the hydrodynamic procedure, described for small animals, is evaluated. Basically, gene transfer is performed by implantation and fixation of a balloon catheter within the suprahepatic vein of anesthetized pigs, through the femoral vein. The catheter tip is identified by fluoroscopy, injecting a contrast solution that marks large or small hepatic territories. Animals were injected with a 100 ml pTG7101 plasmid solution (40 mg/ml), which contains the human alpha-1 antitrypsin gene, perfused at a rate of 7.5 ml/s and efficacy and toxicity of the procedure were evaluated. The results show: (i) the highest efficacy in protein production is reached when perfusion is limited to small areas of the liver; (ii) no relevant hepatic toxicity was observed; (iii) gene transfer is mainly located in the areas around the central vein, as seen in the immunohistochemical studies; (iv) the electron microscopy studies indicate that the areas with good transfection efficacy show the presence of abundant endocytic vesicles that may even fuse among themselves. These data suggest that retrovenous injection by noninvasive interventionist catheterism could become an efficient procedure for hepatic gene transfer with potential clinical applications.
Introduction
The liver is an organ with a high gene therapeutic potential, 1, 2 owing to its many metabolic functions, large size and relatively easy access. As naked DNA is the simplest and safest gene delivery system, 3 multiple approaches have been attempted for in vivo liver gene delivery, [4] [5] [6] [7] [8] [9] although hydrodynamic transfection has become widely used 10 because of its simplicity and high efficiency. In addition, early studies from isolated rabbit liver suggest that catheter-mediated hydrodynamic DNA delivery could be a clinical viable method. 14 The recently suggested mechanism involved in hydrodynamicmediated liver gene transfer 9, [11] [12] [13] offers opportunities to improve the technique and to move it to larger animals, employing catheterization procedures -as suggested by preliminary results from others and our own group. 15, 16 The present study contributes to introduce interventionist catheterism as a noninvasive procedure for liver gene delivery to large animals, determining whether the efficacy of the procedure could be achieved under mild conditions, with potential clinical application.
Results

Catheterization
In anesthetized pigs, a catheter was placed into the liver through the right femoral vein. Two types of catheters without and with balloon were employed, and their ability to perfuse the liver was monitored by fluoroscopy after contrast solution injection. The catheter without balloon was introduced into the liver until the hepatic vein was occluded. The procedure allows the retroperfusion of small areas of the liver using small injection volumes ( Figure 1 , upper panel), although when the volume was increased, vein occlusion was lost, and therefore also the efficiency of retrodynamic injection. To avoid the afore-mentioned problem, and to guarantee hermetic vein closure during perfusion, we used a balloon catheter. The maximal size of the balloon (approximately 2 cm in diameter) does not allow complete occlusion of blood liver circulation, but we were able to occlude and retroperfuse both small and large liver areas ( Figure 1 , lower panel) at a rate of 7.5 ml/min, without loss of hermetic occlusion of the compartmentalized area.
Efficacy of catheter-mediated hAAT gene transfer
In these experiments, the balloon catheter was introduced through the right femoral vein, and then placed into the hepatic vein, employing an appropriate guide. Then, the catheter was fixed by balloon inflation, and the retroperfusion area as well as hermetic vein closure were identified by fluoroscopy after quickly injecting small volumes (5 ml) of contrast solution. Thus, we differentiated two pigs in which perfusion was limited to a small liver area, and two additional pigs in which the liver perfusion area was larger, as shown in Figure 1 left and right lower panel, respectively. In all cases, 100 ml of a saline solution of pTG7101 plasmid (40 mg/ml) was injected at a rate of 7.5 ml/s. Three minutes later, the balloon was deflated, the catheter removed and the pig was allowed to recover from the anesthesia. Blood samples were taken at different timepoints, and human alpha-1 antitrypsin (hAAT) in plasma was determined by enzyme-linked immunosorbent assay (ELISA). The results, summarized in Figure 2 , indicate that the efficacy of gene transfer was better in the case in which retroperfusion was limited to a small liver area. Thus, 10-15 days after gene transfer to a small liver area, the hAAT plasma levels were approximately 200 ng/ml. In contrast, the value was 10 times lower when the gene was retroperfused to a large liver area.
Liver toxicity
The liver injury induced by the catheter-mediated gene transfer procedure was evaluated in the above experiment by measuring the plasma levels of albumin (Alb), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and g-glutamyl transferase (GGT). The results (Table 1) indicate that the procedure mediates very small and very limited liver injury. Thus, in all cases small increases in AST were observed in the 2 or 24 h following gene transfer. No special differences were observed in pigs where liver perfusion was performed in a small or large area.
Immunohistochemistry: liver distribution of hAAT
Two weeks after catheter-mediated liver gene transfer, one pig of each group was killed, the livers were removed and tissue samples were selected from perfused Figure 1 Liver catheterization. In an anaesthetized pig the catheter was introduced through the femoral vein, placed into the liver and its position identified by fluoroscopy after injection of contrast solution. Upper panel: a catheter without balloon was deeply introduced until it was lodged in the vascular bed; the images before (left) and after (right) contrast injection are shown. Lower panel: a catheter with balloon was placed in depth (left) or proximally (right), and after catheter fixation by balloon inflation, the contrast solution was injected to identify the small and large perfused intrahepatic territories, respectively.
Noninvasive interventionist gene therapy SF Aliño et al and non-perfused liver lobes, according to previously fluoroscopy images obtained during plasmid injection experiment. The samples were fixed as described in Materials and methods, and cells producing hAAT in pig hepatocytes were identified by an immunohistochemical procedure. We failed to find specific hAAT immunostaining in the experiment in which retroperfusion was targeted to a large liver area. However, in the experiment in which retroperfusion affected a small liver area, two important results were obtained ( Figure 3) . Firstly, immunostained cells were present only in the liver lobule that was previously transfected (upper and low medium and right panels), but not in the other lobes where catheter-mediated transfection was not carried out (upper and lower left panels). Secondly, the hAATtransfected hepatocytes were located around central veins, but no stained hepatocytes were observed around the periportal areas. Immunostaining was clearly identified at higher magnification (lower right panel) as a brown color within the hepatocyte cytoplasm, in contrast to the blue color of the nucleus.
Quantitative reverse transcriptase-polymerase chain reaction assay
Samples from the same liver areas picked up for immunohistochemical study were also taken for quantification of mRNA transcripts of both hAAT and pig a 1 -antitrypsin (SsAT) gene. The amount of RNA was normalized with respect to an endogenous control gene (GAPDH (glyceraldehyde-3-phosphate dehydrogenase)). The C t was measured in polymerase chain reaction (PCR) cycles at which the reporter fluorescent emission increases beyond a threshold level based on the background. Similar C t values of SsAT were observed in samples from non-perfused (15.970.4) and perfused (16.571.0) liver areas. Also, the GAPDH C t values were similar in non-perfused (17.271.4) and perfused (18.471.1) liver territories and therefore, the normalized SsAT remain unchanged in all the experimental conditions. However, the hAAT gene expression was largely changed in the different liver areas studied (Figure 4 ). Whereas no detectable expression was observed in nonperfused liver lobes, the hAAT gene expression was present in all liver territories in which perfusion was Efficacy of catheter-mediated liver gene transfer. The hAAT gene was delivered to a small or large liver territory by retrovenous injection of 100 ml of a saline solution containing 40 mg/ml of pTG7101 plasmid, at a rate of 7.5 ml/s. The plasma level of hAAT was measured by ELISA.
Noninvasive interventionist gene therapy SF Aliño et al performed. Interestingly, the higher amount was observed in the small perfused areas, in which also human protein can be observed by immunohistochemical procedure.
Ultrastructural liver changes
Recently, we have described that massive endocytic vesicles are involved in the mechanism of hepatocyte gene transfer 13 in mice, employing glutaraldehyde injection as an efficient procedure to 'freeze the image' of what happens in the liver in the first moments after injection. Now, we are interested in determining whether catheter-mediated retrodynamic gene injection into the pig hepatic vein mediates similar morphological changes. In the remaining treated pigs, 2 weeks after transfection, a catheter balloon was placed to perfuse a small liver area, with the help of fluoroscopy and contrast solution injection. With the aim of observing the early morphological changes in hepatocytes induced by the procedure, 100 ml of 2.5% glutaraldehyde solution were retrodynamically injected after balloon inflation, at a rate of 7.5 ml/s. Immediately, the pig was killed and after abdominal laparotomy the catheter (leaving the Figure 3 Liver immunohistochemistry of hAAT. Two weeks after catheter-mediated liver gene transfer, liver samples from different territories were taken for immunohistochemical study. Upper panel: low magnification images from liver sections of a non-perfused liver lobe (a) and a small area perfused lobe (b). Lower panel: higher magnification of the pericentral vein areas of the liver sections from non-perfused liver lobe samples (c) and small territory perfused lobe (d, e). P, portal vein; C, central vein. Figure 4 qRT-PCR. Two weeks after catheter-mediated liver gene transfer, liver samples from different territories were collected. Samples from non-perfused and perfused (large and small areas) territories were used to evaluate the hAAT gene expression. Values were normalized respect to GAPDH gene expression.
Noninvasive interventionist gene therapy SF Aliño et al liver) was cut and the liver removed. Thus, the catheter position within the liver as well as the perfused area were easily identified during necropsy ( Figure 5 ), and samples were collected for transmission and scanning electron microscopy from perfused liver areas and nonperfused lobes.
The results of the transmission electron microscopic study are summarized in Figure 6 . In the upper panel, we see the ultrastructure from non-perfused liver lobule, in which blood vessels and hepatocytes are well identified. Endothelial cells are seen to line a poorly fenestrated vascular bed, and the subendothelial Disse space appears as a quasi-virtual space between the hepatocyte and endothelial cell. In contrast, the images from perfused liver areas show a greatly widened Disse space (0.5-1 mm), and the massive presence of large endocytic vesicles (0.5-2 mm) within hepatocytes -some of them being in direct contact with the subendothelial Disse space ( Figure 6 , middle panel). Also, a massive presence of these vesicles is observed within the hepatocyte cytoplasm, distributed between the two opposite cell surfaces -each connected with a sinusoid. In some cases, these accumulated vesicles fuse to conform a very large vesicular channel ( Figure 6 , lower panel). In the perfused liver areas, the endothelium shows more disruptions than non-perfused areas, although in general it remains poorly fenestrated.
The scanning electron microscopic findings are summarized in Figure 7 . The upper panel shows images from non-perfused liver areas, where the normal liver structure is seen, composed of rows of hepatocytes and sinusoids. The latter drain the blood to central veins, and the endothelium is poorly fenestrated. On the other hand, the bile canaliculi can be observed between the surfaces of two neighboring hepatocytes. In contrast, the images from perfused liver areas (lower panel) show hepatocytes with a spongy cytoplasm mainly in the sinusoidal pole where the vesicles are connected to the subendothelial space, and in-depth they frequently yield a trabecular image as result of intracytoplasmic vesicle fusion. However, this spongy structure was not present at the opposite cell pole alongside bile canaliculi.
Discussion
The present study shows that interventionist catheterism-mediated gene delivery to the pig liver is an easy and safe procedure with potential application for liver gene therapy in large animals. In our hands, the plasmid pTG7101 containing the full hAAT gene was delivered to the pig liver by interventionist retrodynamic injection. We subsequently identified the human protein by ELISA in plasma, and by immunohistochemistry in liver sections. We also suggest methodological improvements to increase the efficacy of the procedure for therapeutic purposes.
Important progress has been made in non-viral liver gene therapy in small animals since the hydrodynamic procedure for liver gene delivery was first described. 5, 17 It has been reported that long-term therapeutic plasma levels of hAAT in mouse plasma can be achieved by the hydrodynamic injection of pTG7101 plasmid in mice, and that the cumulative dose mediates dose-response, with good tolerance. 9, 13 In general, the procedure does not mediate significant liver injury. These results strongly suggest the interest of the procedure for clinical application, although the systemic hydrodynamic perturbation induced by the large injection volume required by the procedure undoubtedly greatly limits its clinical application. Now, we show that noninvasive retrodynamic injection into hepatic vein is an easy procedure to liver gene delivery with high clinical potential, as it reproduces the main changes observed during hydrodynamic gene transfer but circumvents the unacceptable hemodynamic changes.
The main goal of noninvasive hepatic catheterism for gene delivery is to avoid the adverse effects of Noninvasive interventionist gene therapy SF Aliño et al hydrodynamic injection upon the systemic hydrodynamic balance, which can even lead to circulatory collapse and death, mainly as the basic idea is to locally reproduce the intrahepatic conditions that are supposed to facilitate gene delivery into the hepatocytes by means of a noninvasive method. With this purpose in mind, we have reached the suprahepatic vein through the inferior cava vein by means of a catheter inserted into the femoral vein (usually the right vein). It is also possible to reach the suprahepatic through the jugular veins, as also described by other group for clinical applications. 15 Basically, we have worked on two essential points, the first being the choice of catheter type. In this sense, we have used a single-light catheter that allows us to reach the liver and perfuse contrast solution, thereby identifying catheter tip location and the perfused intrahepatic territory. The catheter can be deeply introduced, sealing off the lumen but, if the perfusion rate is increased, the catheters can no longer guarantee closure of the territory, and retroperfusion is partially compromised as a result. We then evaluated a balloon catheter in order to fix its intrahepatic position. Using this kind of catheter, we could differentiate two perfusion areas within the liver. When the catheter is deeply introduced, it allows the perfusion of reduced liver territories, whereas catheter fixation in locations closer to the cava vein allows the perfusion of relatively large areas comprising one or more lobes. Our observations suggest that size difference between small and large liver areas was 10-fold approximately, but no objective parameters, such as volume or weight, were measured in these experiments, as the exact limits of the perfused areas are macroscopically not well defined. Once these two intrahepatic areas were defined, we examined how catheter location affects hAAT gene transfer, using the same perfusion conditions. We employed a plasmid concentration that had already been shown to generate the maximum transfection effect in the hydrodynamic murine model. 9, 13 In this way, 100 ml of pTG7101 solution (40 mg/ml) were perfused at a rate of 7.5 ml/s in small or large liver territories. After gene transfer, the animals recovered and the plasma levels of the human protein were quantified in the following 2 weeks, as we have previously described that the kinetics of hAAT gene expression in Figure 6 Transmission electron microscopy. In an anaesthetized pig, a small liver territory was perfused with a 2.5% glutaraldehyde solution by means of a catheter (100 ml at 7.5 ml/s), previously fixed with an inflated balloon. Ultrastructural changes in samples from nonperfused liver lobule (upper panel) and the small perfused territory (middle and lower panel) are presented. H: hepatocyte; M: blood mononuclear cell; D and white asterisk: Disse space; E: endothelium; N: nucleus; Black asterisk: endocytic vesicles.
Noninvasive interventionist gene therapy SF Aliño et al this gene construct increases gradually to reach a peak 10-15 days after transfection. The results show that hAAT levels of 200 ng/ml were reached 10-15 days after transfection in the cases where perfusion had been targeted to a small liver territory. On the other hand, when perfusion reached large liver territories, the observed efficacy was much lower, suggesting that under these circumstances the optimal conditions of volume and/or pressure 12, 13 required to guarantee gene transfer were not reached. With the aim of clarifying the details of the phenomena occurring during this process, the animals were killed and liver samples from the perfused and non-perfused lobes of the same animal were collected. We consider that absolute duration of hAAT expression is an important parameter but the low protein levels obtained, as compared to the expected from mouse experiments, were not worth making the assay longer. Therefore, we decided to kill the animals in order to make additional studies reinforcing our findings. As fluoroscopy is not enough for sure identification of the transfected lobe, we took several samples from the candidate lobe (the one that we think that had been perfused) as well as from the rest of the lobes, including those that we are sure that have not been perfused (controls). Later, the reverse transcriptase-PCR (RT-PCR) and immunohistochemical results, confirmed our suspects about which was the transfected lobe. Immunohistochemistry showed that as long as the non-perfused lobes or large perfused territories exhibited negative hAAT staining, the small perfused territories showed positive staining around the central vein. This particular distribution agrees with that previously described by other authors and by our own group 6,9 regarding hydrodynamic transfection in mice, and also supports the idea that perfusion in very localized liver territories reproduces the optimal gene transfer conditions described by the hydrodynamic procedure. The images of Figure 3 are representative of the tissue sections studied.
Although the percentage of transfected hepatocytes would be an interesting parameter, we have not made a morphometric analysis because the small size of the achieved perfused area would not give robust conclusions. It should be noted that when working in animals with larger perfused territories, we failed to identify positive immunohistochemical staining. However, we were able to identify the hAAT gene expression by realtime RT-PCR in larger perfused territories and interestingly, two orders of magnitude higher amount was observed in the small perfused areas, in which also the human protein can be observed by immunohistochemical procedure. However, it remains to be clarified why there is a 100-fold increase in mRNA amount but only a 10-fold increase in protein when comparing small versus large perfused liver areas.
In order to evaluate the extent to which cathetermediated gene transfer could trigger liver damage, we collected blood samples immediately after transfection, to measure enzyme markers of liver injury. The results show that only AST shows a small increase 2-24 h posttransfection, although normal levels are quickly recovered after that time. These results agree with the observation that liver injury induced by the hydrodynamic injection of hAAT gene in mice is transient and not serious. 13 Light microscopy does not show the presence of microscopic lesions in the liver tissue, although we wanted to evaluate the ultrastructural alterations that could be caused by intrahepatic perfusion. This is particularly relevant, as we have recently proposed 13 that gene transfer induced by the hydrodynamic procedure seems to be mediated via the massive presence of endocytic vesicles of large size in the affected territory. In our experiments, glutaraldehyde perfusion could have been performed in the same previously perfused lobe. We consider that a repeated injection in the same lobe should not give different structural changes compared to Figure 7 Scanning electron microscopy. In an anaesthetized pig, a small liver territory was perfused with a 2.5% glutaraldehyde solution by means of a catheter (100 ml at 7.5 ml/s rate), previously fixed with an inflated balloon. Ultrastructural changes in samples from non-perfused liver lobule (upper panel) and the small perfused territory (lower panel) are presented. S: sinusoid; H: hepatocyte; E: endothelium; C: bile canaliculi.
Noninvasive interventionist gene therapy SF Aliño et al a single injection, as our previous studies indicate that the morphological changes are very transitory, and multiple accumulative doses (10 days apart) are well tolerated and mediate a good dose-response protein production. 9, [11] [12] [13] The transmission electron microscopic study of the control tissue revealed the preservation of typical liver tissue (hepatocytes related to scarcely fenestrated sinusoidal endothelium, with a near-virtual Disse space), whereas the glutaraldehyde perfused tissue revealed the massive presence of endocytic vesicles lining the hepatocyte surface. In these cases, we also found the vesicles to be clearly internalized, and could even identify accumulations of vesicles within the hepatocytes. Such accumulated vesicles sometimes fused among each other, yielding the appearance of genuine intracellular channels.
These transmission electron microscopy images were confirmed by the scanning electron microscopic study. In the perfused areas, we observed more dilated canaliculi, a scarcely fenestrated endothelium and hepatocytes containing abundant endocytic vesicles -some of which generated a reticular structure, suggesting the fusion of vesicles to produce more complex structures within the cells.
This reticular image was seen essentially in the vascular pole, and did not appear in the pole related with the bile canaliculi. These observations agree with those previously described in murine models, and confirm that administration by catheterization involves a functional and morphological response in the small perfused territories, equivalent to that seen after hydrodynamic injection in small animals. This suggests that, under the described conditions, it is possible to reproduce hydrodynamic gene transfer in large animals, avoiding the hydrodynamic adverse effects that limit possible application in clinical practice. Thus, we observe an important relationship between the injected volume and the size of injected area, but it results very difficult to predict the exact volume required for a concrete size area. In this respect, we consider that the gene transfer efficacy in the small areas is most probably due to the high pressures achieved. Unfortunately, this parameter was not measured in our experiments, as we used a single lumen catheter. Thus, we do not know the pressure threshold required for an efficient gene transfer. The finding of this pressure threshold could be a good parameter for defining the optimal volume for gene transfer in each liver perfusion. In this respect, our experiments are the first approaches in order to reach efficient conditions of gene transfer. We hope that future experiments, employing a catheter with an additional lumen (for pressure measurement during injection) will contribute to know the required pressure threshold. The fact that the best responses were achieved with localized perfusions suggests the need for larger diameter catheters capable of massively perfusing a larger liver territory without pressure loss -as such pressure is necessary for facilitating gene transfer and/or the morphological changes required for such transfer to take place. In this respect, the use of a balloon catheter with three lumens could allow the simultaneous measurement of intravenous pressure during perfusion, and would contribute to define the pressure threshold required to ensure gene transfer efficacy. Our findings show that in those cases in which perfusion reached a larger hepatic volume, where we expect lower intravenous pressures, we were not able to detect specific immunohistochemical staining or ultrastructural morphological changes. For this reason, coming experiments should focus on the development of larger caliber catheters with a triple lumen -one for a balloon allowing complete closure of the hepatic vein at its more proximal point related to the cava vein; another for pressure monitorization; and a third for gene transfer perfusion. In this way, it would be possible to increase the perfusion rate, achieving levels of uniform pressure over a large liver mass, which should allow sufficiently effective gene transfer to reach therapeutic efficacy. 
Materials and methods
Animals
Reagents
Goat anti-hAAT antibodies (non-conjugated and peroxidase conjugated) were obtained from Sigma (Sigma Chemical Co., Madrid, Spain), and the immunohistochemical developing system LSAB from Dako (Glostrup, Denmark). pTG7101 is a plasmid containing the full length of the human AAT. The plasmid was a generous gift from Dr P Meulien and Dr JP Lecocq (Transgène SA, Strasbourg, France). The pTG7101, 18.6 kb plasmid, employed in the present work contains a 16.5 kb genomic fragment of the hAAT gene, cloned in the SalI site of Poly III-I plasmid. In addition, it contains a 1.8 kb genome sequence upstream promoter, the promoter and full length of human AAT gene and 3.2 kb downstream gene.
In vivo gene transfer in the pig
Anesthesia of female pigs (25-30 kg) was induced with ketamine (5 mg/kg), medetomidine (10 mg/kg) and azapirone (2 mg/kg), and was maintained with 2% propozole (10-15 ml/h). After femoral dissection, a catheter (without or with balloon) was introduced and placed into the hepatic vein from the inferior cava vein. The location of the catheter was observed by X-ray imaging and the perfusion of Ultravist 370 contrast solutions (Iopramida, Schering, Valencia, Spain). In a typical experiment, the catheter was fixed within the vein by balloon inflation, and then pTG7101 plasmid in saline solution (40 mg/ml) was retrovenously injected (7.5 ml/ s) employing a pump (Injektron 82M, Medtron, Saarbrü cken, Germany). Three minutes after injection, the balloon was deflated and then the catheter was removed. Blood samples were taken from ear veins, and plasma was obtained and kept at À201C until ELISA assay and biochemical study of liver injury. In some experiments, the liver was retrovenously perfused with 2.5% glutaraldehyde saline solution, under conditions similar to those used for gene transfer, as indicated above. The animals were killed with an intravenous KCl injection, the liver was removed, and after locating the catheter within the liver, samples of tissue were obtained for histology.
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ELISA of hAAT in pig plasma
The hAAT in pig plasma was quantified by ELISA, as described previously. 18 Briefly, goat anti-hAAT (0.2 mg/well) and goat anti-hAAT peroxidase conjugate (1.5 mg/well) were used as capture and detecting antibodies, respectively. In our experiments, the limit of human protein detection was 1 ng/ml. The enzymatic reaction was induced with o-phenylenediamine (0.4 ng/ml, in citrate-phosphate buffer, pH 5) with 30% H 2 O 2 (1.5 ml/ml). The reaction was stopped 2.5 min later by adding 2 M H 2 SO 4 .
Immunohistochemical staining of hAAT in pig liver
Livers were fixed in 4% paraformaldehyde and embedded in paraffin. Immunostaining was carried out as described previously. 9 Briefly, deparaffinized tissue sections were incubated with 4% bovine serum albumin in phosphate-buffered saline (1 h, 371C) . Then, the tissue sections were incubated in antibody solution (1:300 diluted rabbit anti-hAAT) at 371C for 1 h. Detection was carried out using the peroxidase kit LSAB-2. Tissue was counterstained with hematoxylin before dehydration.
Quantitative RT-PCR
Liver samples were cut into small pieces, and homogenized in Tri Reagent (Ambion, Bionova, Madrid, Spain) with an Ultra-Turrax homogenizer. Subsequently, the RNA samples were treated with RNase-free DNase (Gibco, Prat de Llobregat, Barcelona, Spain). Further purification with RNeasy mini kit (Qiagen, Valencia, Spain) was performed before spectrophotometry quantification. The retrotranscription to cDNA was performed using 1 mg total RNA (DNA free), random examers and high capacity cDNA archive kit (Applied Biosystems, Madrid, Spain). For quantitative RT-PCR (qRT-PCR), power SYBR green PCR master mix (Applied Biosystems) was employed according to the instructions of the manufacturer.
The oligonucleotides were designed with Primer Express software (Applied Biosystems) using the next accession numbers: K02212, X01683 (human AAT) and NM_214395 (pig AAT), AF017079 (pig GAPDH). The primers specific for pAAT (forward (FW): 5 0 -GACACGC TGTCCAGGAGACA-3 0 ; reverse (RV): 5 0 -AGGCGGCTT CCTGATGTTG-3 0 ), for pGAPDH (FW: 5 0 -CAGCAATGC CTCCTGTACCA-3 0 ; RV: 5 0 -GATGCCGAAGTTGTCATG GA-3 0 ) and hAAT (FW: 5 0 -GAGGGCCTGAATTTCAA CCTC-3 0 ; RV: 5 0 -CCAGGAACTTGGTGATGATAA-3 0 ) were used. The precise amount of RNA (based on optical density) and its quality (lack of degradation) was normalized with respect to an endogenous control gene (GAPDH). The method used for obtaining quantitative data of gene amount and relative gene expression was the comparative C t method as described by the manufacturer (PE-ABI PRISM 7700 Sequence Detection System; User Bulletin No. 2). The DC t value represents the C t difference from reference and specific genes. The derived 2 ÀDCt parameter is an easy variable directly relating the increased values of 2
ÀDCt with increased amounts of PCR product.
Electron microscopy
Pigs were retrodynamically injected through the catheter placed in the hepatic vein with 100 ml of 2.5% glutaraldehyde at a rate of 7.5 ml/min. Small tissue pieces from different liver areas were removed and immersed in phosphate Sørensen buffer (pH 7.4) solution containing 2.5% glutaraldehyde. For transmission electron microscopy, multiple 1-mm 3 pieces of liver were routinely processed and embedded in epoxy resin. Ultrathin sections, stained with uranyl acetate and lead citrate, were examined under a Jeol JEM-1010 electron microscope. For scanning electron microscopy, pieces of liver slices (2 mm thick) were routinely processed. Briefly, samples remained in 2.5% glutaraldehyde solution overnight at 41C, and were post-fixed in 1% aqueous osmium tetroxide. After dehydration in an ethanol series and critical point drying, the samples of liver were fractionated and mounted onto plate supports and then sputter-coated with gold. The samples were viewed under a Hitachi S-4100 scanning electron microscope at 10 kV.
